These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35367397)

  • 1. Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease.
    Dhiman A; Handa M; Ruwali M; Singh DP; Kesharwani P; Shukla R
    Mitochondrion; 2022 May; 64():112-124. PubMed ID: 35367397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
    Gan X; Huang S; Wu L; Wang Y; Hu G; Li G; Zhang H; Yu H; Swerdlow RH; Chen JX; Yan SS
    Biochim Biophys Acta; 2014 Feb; 1842(2):220-31. PubMed ID: 24252614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial defects: An emerging theranostic avenue towards Alzheimer's associated dysregulations.
    Mani S; Swargiary G; Singh M; Agarwal S; Dey A; Ojha S; Jha NK
    Life Sci; 2021 Nov; 285():119985. PubMed ID: 34592237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
    Rai SN; Singh C; Singh A; Singh MP; Singh BK
    Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Mitochondrial Malfunction in Alzheimer's Disease: New Therapeutic Hope.
    Nabi SU; Khan A; Siddiqui EM; Rehman MU; Alshahrani S; Arafah A; Mehan S; Alsaffar RM; Alexiou A; Shen B
    Oxid Med Cell Longev; 2022; 2022():4759963. PubMed ID: 35607703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    Tönnies E; Trushina E
    J Alzheimers Dis; 2017; 57(4):1105-1121. PubMed ID: 28059794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between β-Amyloid and Mitochondrial Dynamics.
    Kim DI; Lee KH; Oh JY; Kim JS; Han HJ
    Cell Mol Neurobiol; 2017 Aug; 37(6):955-968. PubMed ID: 27766447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.
    Selfridge JE; E L; Lu J; Swerdlow RH
    Neurobiol Dis; 2013 Mar; 51():3-12. PubMed ID: 22266017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's pathogenesis and its link to the mitochondrion.
    Simoncini C; Orsucci D; Caldarazzo Ienco E; Siciliano G; Bonuccelli U; Mancuso M
    Oxid Med Cell Longev; 2015; 2015():803942. PubMed ID: 25973139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
    Ponne S; Kumar CR; Boopathy R
    Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    Guo L; Tian J; Du H
    J Alzheimers Dis; 2017; 57(4):1071-1086. PubMed ID: 27662318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease.
    Awasthi S; Hindle A; Sawant NA; George M; Vijayan M; Kshirsagar S; Morton H; Bunquin LE; Palade PT; Lawrence JJ; Khan H; Bose C; Reddy PH; Singh SP
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
    Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
    Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
    Bonda DJ; Wang X; Perry G; Smith MA; Zhu X
    Drugs Aging; 2010 Mar; 27(3):181-92. PubMed ID: 20210366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer's disease: A comprehensive review.
    Jin X; Guo JL; Wang L; Zhong X; Yao WF; Gao H; Liu MY
    Eur J Med Chem; 2021 Jun; 218():113401. PubMed ID: 33831779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disentangling Mitochondria in Alzheimer's Disease.
    Johri A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.